Pius-Hospital, Oldenburg
Oldenburg, Germany
General hospital in Oldenburg, Lower Saxony
Georgstraße 12, 26121 Oldenburg
About Pius-Hospital, Oldenburg
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Ulm
7
AIO-Studien-gGmbH
4
Boehringer Ingelheim
4
Hoffmann-La Roche
4
Janssen Research & Development, LLC
4
Clovis Oncology, Inc.
3
Pfizer
3
Takeda
3
Ariad Pharmaceuticals
2
ETOP IBCSG Partners Foundation
2
Lung Cancer Group Cologne
2
Clinical Trials at Pius-Hospital, Oldenburg
During the past decade, Pius-Hospital, Oldenburg conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 12 clinical trials were completed, i.e. on
average, 34.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy
2006-09-26
2014-04-14
Completed
132
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
2006-09-01
2014-06-01
Completed
1,252
Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years
2001-10-01
2008-01-01
Unknown status
600
A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer
2007-01-01
2011-02-01
Completed
111
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer
2008-12-03
2017-11-13
Completed
1,314
Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)
2009-06-01
2016-05-01
Completed
90
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Pius-Hospital, Oldenburg" #1 sponsor was "University of Ulm" with 7 trials, followed by "AIO-Studien-gGmbH" with 4 trials
sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Janssen Research & Development, LLC"
with 4 trials sponsored. Other sponsors include 34 different institutions and
companies that sponsored additional 35 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Pius-Hospital, Oldenburg"
#1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Amgen" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "Novartis Pharmaceuticals" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were
collaborators in the rest 32 trials.
Clinical Trials Conditions at Pius-Hospital, Oldenburg
According to Clinical.Site data, the most researched conditions in "Pius-Hospital, Oldenburg" are
"Carcinoma, Non-Small-Cell Lung" (12 trials), "NSCLC" (5 trials), "Non-Small Cell Lung Cancer" (5 trials), "Acute Myeloid Leukemia (AML)" (4 trials) and "Acute Myeloid Leukemia" (3 trials). Many other conditions were trialed in "Pius-Hospital, Oldenburg" in a lesser frequency.
Clinical Trials Intervention Types at Pius-Hospital, Oldenburg
Most popular intervention types in "Pius-Hospital, Oldenburg" are "Drug" (54 trials), "Other" (7 trials), "Biological" (6 trials), "Radiation" (3 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Pemetrexed" (11 trials), "Carboplatin" (10 trials), "Cisplatin" (7 trials), "Placebo" (6 trials) and "Cytarabine" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Pius-Hospital, Oldenburg
The vast majority of trials in "Pius-Hospital, Oldenburg" are
61 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Pius-Hospital, Oldenburg
Currently, there are NaN active trials in "Pius-Hospital, Oldenburg".
undefined are not yet recruiting,
10 are recruiting,
14 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 25 completed trials in Pius-Hospital, Oldenburg,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Pius-Hospital, Oldenburg, 4 "Phase 1"
clinical trials were conducted, 26 "Phase 2" clinical
trials and 28 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".
Departments of Pius-Hospital, Oldenburg
Pius-Hospital, Oldenburg has several departments that took part in Clinical trials: "Pius-Hospital; Klinik fuer Haematologie und Onkologie" - 9 trials
Departments List
Name
City
Trials